Åsa Ohlsson, research leader for the group at SLU that has been tasked with leading the project “Epigenetic modifications linked to the development of cardiomyopathy” during the period 2024-2027. Photo: Lisa Chröisty, SLU
The mystery of heart muscle disease—Can cats help us find the answers?
Page reviewed:
30/09/2026
Both cats and humans suffer from the serious heart muscle disease known as cardiomyopathy—a fatal condition that, as of today, cannot be predicted based on either genetics or environmental factors. Could researchers find the answers in cats—and then apply that knowledge to help humans as well?
Cardiomyopathy, a complex term that can be loosely translated as “heart muscle disease.” It is a group of diseases that can manifest in various forms and affect cats, dogs, and humans alike.
When humans are diagnosed with this condition, there is often only one solution: a heart transplant. For our animals, however, it is currently an incurable disease—one in which veterinarians can only help alleviate pain and discomfort.
In order to find new ways to both cure and prevent this serious disease, the big question is now being brought into the spotlight: What actually causes the disease?
The cat's heart - unlocking opportunities to find the answers
We already know that these heart diseases are often genetically linked, but it’s not quite that simple, because the disease can apparently also skip generations or affect only certain siblings, and we don’t know why—yet. But this clearly suggests that there’s more to it than just our DNA, says Åsa Ohlsson, project manager for the research project.
As a result, researchers are now looking for other possible explanations—both factors that may occur within the body and those that may be influenced by substances we are exposed to in our environment.
Could the cat's heart be the key to new discoveries about the heart disease cardiomyopathy? Photo: Lisa Chröisty
As with many other diseases, it is possible to study the affected organ as the disease progresses in the body through a biopsy. In this procedure, a very small piece of the organ is removed and examined.
But when it comes to heart disease, this is not an option. The heart is difficult to biopsy without disrupting its vital function in the body. Therefore, the only way to study hearts—whether healthy or diseased—is through postmortem sampling.
What we therefore need to conduct further research is fresh heart tissue. But it is often both ethically and morally difficult to justify gaining access to a deceased person’s heart within just minutes of their death, says Åsa Ohlsson, adding:
When it comes to our pets, however, the attitude is often different—not least because pet owners often want to prevent others from going through what they themselves have experienced.
That is why researchers are now turning to animals—cats and dogs—to learn more about the possible causes of cardiomyopathy. A fantastic opportunity, since the diseases are very similar in cats, dogs, and humans. In this way, the researchers hope not only to increase our understanding of the development of cardiomyopathy in our most common pets, but also, hopefully, to eventually apply this knowledge to humans as well.
The mystery behind what changes the expression of our DNA
All of our traits are “written” in what is known as our DNA: like a long code contained in all of our cells, regardless of whether they are brain, skin, or heart cells.
A cell’s function is determined by the fact that it has access only to a tiny, tiny portion of the DNA code that is “unlocked” and thus readable by that particular cell. The rest of the code is also present—in every single cell—but it is locked and inaccessible. This is partly why a brain cell functions as a brain cell and not as a liver cell.
But this can change—partly due to malfunctions in the body’s mechanisms that are supposed to ensure that the right areas are locked or unlocked, and partly due to environmental factors and lifestyle habits.
We know that our lifestyle can influence the development of disease, and this is certainly true when it comes to cardiomyopathy. There are naturally occurring substances in our environment, as well as chemicals to which we are exposed, that can alter how the DNA in a cell is “open” or “inaccessible” for reading. This can then lead to the cells losing the ability to perform their intended function. And that’s what we need to investigate—and hopefully find answers to, says researcher Åsa Ohlsson.
The dream scenario: Unlocking a historical treasure trove of information
In addition to the heart samples from the cats and dogs participating in the study, there is also a large research bank containing historical heart tissue collected over many decades from animals that have undergone autopsies. However, no one has yet found the right method for examining and comparing these samples. This is because there are significant challenges associated with this type of archived tissue, which has often deteriorated over time—making the process more difficult. So, if researchers want to use such tissue to answer the question of whether cardiomyopathy is a heart muscle disease, they need to refine their methods.
If we crack that code, we’ll have a goldmine of data to examine and compare with historical data to see how generations of cats, dogs, and even humans have inherited this disease—and in which cases it has manifested and why.
This would lend a whole new level of significance to our understanding of why these heart defects occur. And—it might open the door to many more, as yet unexplored, possibilities.
A study combining many techniques to solve the mystery of this complex group of diseases. The study will examine three forms of cardiomyopathy in greater detail: DCM (the most common form in dogs), HCM, and RCM (the most common and second most common forms in cats). All three forms also affect humans to varying degrees. Photo: Lisa Chröisty
Ready, set, go.
Since the disease variants DCM, HCM, and RCM all occur in humans, both cats (which are primarily affected by HCM and RCM) and dogs (which, on the other hand, most often develop DCM) will participate in the project. The goal is to lay the groundwork for subsequently applying the findings to humans.
The project has just gotten started, and we have three truly exciting years ahead of us. Perhaps the findings will help bring about future changes in medicine and help save the lives of those who would otherwise be affected by the heart condition cardiomyopathy.
“If we can increase the likelihood that more animals and humans will live dignified and long lives, then we will have succeeded. I hope that we can at least make some progress in that direction,” concludes Åsa Ohlsson.
Support research at SLU
Your gift contributes to research and education that generate new knowledge for sustainable life – for people, animals, nature and society
The research project is funded by Formas with 2,999,601 SEK.
It was launched at the turn of the year 2023/2024 and is expected to continue through the turn of the year 2026/2027.
The project is led by researcher Åsa Ohlsson and a research team at SLU consisting of:
Ingrid Ljungvall, cardiologist and veterinarian
Jens Häggström, cardiologist and veterinarian
Göran Andersson, professor in molecular genetics
Fredrik Södersten, pathologist and veterinarian
The project is planned to be carried out in three phases, briefly described as follows:
Evaluate whether there are epigenetic modifications of DNA that can be linked to the heart disease cardiomyopathy in cats and dogs by studying freshly collected heart tissue from cats and dogs.
Examine stored tissue from the same individuals from whom fresh tissue was collected in an effort to identify methods capable of detecting these epigenetic modifications in both fresh and stored heart tissue. The successful methods will then be used to examine other archived tissue as well—a repository of information that is currently inaccessible—but which could become a valuable resource with the right methods.
As the study progresses, the plan is to apply the same methods that have been developed to archived human heart tissue.
Read more interviews with researchers
that simply explains the exciting projects we're currently working with